Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Revenue (2016 - 2025)

Marimed (MRMD) has disclosed Revenue for 15 consecutive years, with $41.6 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 6.93% to $41.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $160.0 million through Dec 2025, up 1.31% year-over-year, with the annual reading at $159.8 million for FY2025, 1.34% up from the prior year.
  • Revenue for Q4 2025 was $41.6 million at Marimed, up from $40.8 million in the prior quarter.
  • The five-year high for Revenue was $41.6 million in Q4 2025, with the low at $24.6 million in Q1 2021.
  • Average Revenue over 5 years is $36.1 million, with a median of $37.2 million recorded in 2023.
  • The sharpest move saw Revenue skyrocketed 238.9% in 2021, then dropped 2.05% in 2025.
  • Over 5 years, Revenue stood at $31.0 million in 2021, then grew by 15.42% to $35.8 million in 2022, then rose by 8.57% to $38.9 million in 2023, then grew by 0.13% to $38.9 million in 2024, then increased by 6.93% to $41.6 million in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $41.6 million, $40.8 million, and $39.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.